Veterinary Medicine
Green Zebras S.A. actively seeks collaboration opportunities to develop scientific projects based on therapeutic solutions with high commercialisation potential. Projects may be at any stage of development – from early medical hypotheses, through molecular target identification and validation, to preclinical and clinical studies.
Many therapeutic modalities with a strong biological rationale in human medicine – such as monoclonal antibodies, antibody-drug conjugates (ADCs), regulatory proteins, and small molecules – also demonstrate significant translational potential in veterinary medicine, particularly in canine indications. Green Zebras focuses on therapies for companion animals (dogs, cats, and horses), enabling partners to expand human drug development programmes into an attractive and complementary veterinary market.
In veterinary medicine projects, Green Zebras provides end-to-end support throughout the research process, up to market launch as a medicinal product for companion animals (dogs, cats, and horses).
For early-stage translational medicine projects, Green Zebras offers a collaboration model that includes the full package of preclinical studies in animals. Partners gain unrestricted access to the complete set of preclinical data to support further development of therapies for humans, while Green Zebras retains the rights to develop the molecule in the veterinary segment.
For advanced projects already at the clinical stage, Green Zebras offers collaboration opportunities to support the development and commercialisation of the molecule for veterinary applications.
To this end, the company welcomes discussions with scientists and research teams who recognise the therapeutic potential of their work and are interested in further development and commercialisation.
To initiate a collaboration, please complete our questionnaire. This will allow us to understand the therapeutic area of your project, assess its stage of development, and facilitate direct contact.
